We found that breast cancers in the majority of these cases were positive for ER (68%, n = 19 out of 22), highly proliferative as indicated by Ki-67 staining (77%, n = 17 out of 22), and frequently had high-level amplifications (66%). This evidence concerns the gene ESR1 and breast cancer.